Back to top

H.C. Wainwright Sticks to Their Buy Rating for Sana Biotechnology (SANA)

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Sana Biotechnology today and set a price target of $11.00. The company’s shares clo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sana Biotechnology, Inc. (SANA)